1. Home
  2. News & Publications
  3. Publications
  4. Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia.

How to access multiple datasets

Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia.

Leukemia (AML)

Acute Myeloid Leukemia (Credit: National Cancer Institute)

Kurtz SE, Eide CA, Kaempf A, Mori M, Tognon CE, Borate U, Druker BJ, Tyner JW.
Leukemia
https://pubmed.ncbi.nlm.nih.gov/30082821/
PROGRAM:
CTD²
Last Updated:

Content on this page maintained by the Office of Cancer Genomics